Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03799484 · ClinicalTrials.gov registry record · Phase 4
Botulinum Toxin Type A Injection After Topical Anesthesia Versus Petrolatum Ointment
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT03799484: Completed Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
NCT03799484 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 14 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03799484, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether there is a difference in clinical effect, duration of effect, level of discomfort and patient satisfaction in patients receiving topical anesthesia on one side of the forehead and petrolatum ointment on the other prior to Botulinum Toxin Type A administration for the treatment of forehead rhytides.
Primary Outcome
Participants will be asked to raise the brows, and the excursion of the brow from resting position to maximum elevation will be measured in millimeters.
Interventions
- DRUG Botulinum toxin type A
- DRUG 2.5% lidocaine/2.5% prilocaine
- DEVICE petrolatum ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-01-04 |
| Est. Completion | 2019-06-14 |
| Phase | Phase 4 |
What the finished NCT03799484 record still lists
NCT03799484 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Botulinum toxin type A is the first listed.
NCT03799484 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03799484 about?
NCT03799484 is a clinical study titled "Botulinum Toxin Type A Injection After Topical Anesthesia Versus Petrolatum Ointment". The purpose of this study is to determine whether there is a difference in clinical effect, duration of effect, level of discomfort and patient satisfaction in patients receiving topical anesthesia on one side of the forehead and petrolatum ointment on the other prior to Botulinum Toxin Type A admin...
What is the current status of trial NCT03799484?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2019-01-04. Estimated completion is 2019-06-14.
What interventions are being tested in trial NCT03799484?
The interventions under investigation include: Botulinum toxin type A (DRUG), 2.5% lidocaine/2.5% prilocaine (DRUG), petrolatum ointment (DEVICE).
Who is sponsoring clinical trial NCT03799484?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03799484's enrollment target sits among peer trials
14 1901st of 2000 higher than 91 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy